BAb and MxA as functional biomarkers in routine clinical laboratories for the determination of anti-IFN-beta antibodies and their bioactivity levels in multiple sclerosis patients


Cakal B., Uygunoglu U., Saip S., Altintas A., Siva A., Badur S.

Journal of Immunoassay and Immunochemistry, vol.35, no.4, pp.398-411, 2014 (SCI-Expanded, Scopus) identifier identifier